Oxaprozin Articles
Caraco expects $35M revenues in 2003
24 February 2003
Caraco gets US OK for metformin/tramadol
4 February 2002
Caraco gets FDA approval for oxaprozin.
21 January 2002
Opponents of Claritin bill claim Senate win
5 July 2000
Anti-S 1172 campaign underway in three states
4 August 1999
Mobic's US prospects boosted by Abbott deal
11 March 1999
Healthy Third-Quarter Growth For US Drug Majors
22 October 1998
Healthy Second-Quarter Growth For US Drug Firms
29 July 1998
Merged AHP/Monsanto Will Be Top US Drugmaker
15 June 1998
Strong Growth For US Drug Firms In 1997
28 January 1998
Yamanouchi To Develop Searle's Celecoxib In Japan
29 April 1996
Mixed Results For Q4 1995 From US Drug Majors
29 January 1996
Many US Biotech Firms See Good 3rd Qtr Sales Growth
13 November 1995
Solid 3rd Qtr Growth For Large Pharma Cos
31 October 1994
US CHEMICAL/DRUG COs SHOW 1st QTR GROWTH
9 May 1994
POSSIBLE EXTENSION ON PROTECTION FOR DAYPRO
6 December 1993
FDA APPROVES 26 NEWDRUGS IN 1992
25 January 1993
FDA APPRO FOR SEARLE'S DAYPRO
9 November 1992
Showing 1-24 of 24 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
